Hologic Secures Major Patent Victory Against Siemens in European Mammography Technology Dispute Hologic has announced a significant legal victory in Europe after the Unified Patent Court (UPC) in Germany ruled…
BioTools Innovator VANGUARD and BARDA Launch ReadyDetect Competition to Advance At-Home Blood Collection Technologies BioTools Innovator VANGUARD, in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), has announced…
Senopsys Celebrates 20 Years of Advancing Patient-Friendly Medicines Through Sensory Science Senopsys, a company recognized for its expertise in sensory science and pharmaceutical palatability solutions, is marking its 20th anniversary…
Aleve Launches Project DIY Campaign Featuring Dave and Jenny Marrs to Celebrate Passion Projects and Long-Lasting Pain Relief Aleve®, one of the leading over-the-counter pain relief brands, has unveiled a…
Fujifilm and HORIBA Co-Develop High-Sensitivity Inline Raman Measurement System to Advance Biopharmaceutical Manufacturing FUJIFILM Corporation and HORIBA, Ltd. have announced the joint development of a high-sensitivity inline Raman measurement system…
Guided Therapeutics Submits Positive LuViva Clinical Trial Results to FDA, Demonstrating Enhanced Detection of Precancerous Cervical Disease Guided Therapeutics, Inc., a medical technology company focused on improving cervical cancer detection…
Emmecell Secures Strategic Financing to Advance Magnetic Cell Delivery Technology for Ophthalmic Diseases Emmecell, a clinical-stage biotechnology company focused on developing innovative magnetic cell delivery technologies for the treatment of…
Simulations Plus Agrees to $375 Million Acquisition by Altaris, Signaling New Chapter in AI-Driven Drug Development Simulations Plus, Inc., a recognized leader in model-informed drug development and artificial intelligence-enabled pharmaceutical…
Pelago Bioscience Expands Drug Discovery Capabilities Through Acquisition of RG Discovery Pelago Bioscience, a leading contract research organization (CRO) specializing in cell-based target engagement technologies, has announced the acquisition of…
Takeda Presents New Phase 3 Data Showing Oveporexton Improves Daily Functioning, Cognition, and Sleep in Narcolepsy Type 1 Takeda has unveiled additional findings from its pivotal Phase 3 clinical development…
OM Pharma Presents Preliminary REACH Study Findings Demonstrating Real-World Benefits of Broncho-Vaxom® in Preventing Recurrent Respiratory Tract Infections OM Pharma has announced the presentation of preliminary results from its landmark…
Incyte Reports Positive Phase 3 frontMIND Results Showing Tafasitamab and Lenalidomide Plus R-CHOP Improves Outcomes in High-Risk DLBCL and HGBL Incyte has announced positive results from its pivotal Phase 3…